Table 2.
Comparison of changes in laboratory tests of ADMSCs treatment and control groups by days.
| Laboratory tests | MSC transplantation group (n = 10) | Control group (n = 20) | p |
|---|---|---|---|
| 0 days | |||
| CRP (mg/mL) | 207 (32–334) | 100 (16–313) | 0.031 |
| PCT (mg/mL) | 3.64 (0.65–100.0) | 1.17 (0.07–24.0) | 0.009 |
| Laktat (mmol/L) | 1.42 (0.82–3.17) | 1.69 (0.80–9.96) | 0.350 |
| WBC (103/μl) | 17100 (3070–41800) | 12230 (680–24700) | 0.074 |
| AST (μ/L) | 49 (19–158) | 26 (10–2205) | 0.231 |
| ALT (μ/L) | 34 (3–861) | 19 (5–1437) | 0.713 |
| Platelet (103/μl) | 156000 (26000–479000) | 200500 (18000–575000) | 0.373 |
| 5 days | |||
| CRP (mg/mL) | 82 (20–275) | 64 (11–185) | 0.562 |
| PCT (mg/mL) | 2.24 (0.48–100.0) | 0.50 (0.40–1.78) | 0.777 |
| Laktat (mmol/L) | 1.31 (0.63–2.84) | 1.23 (0.54–2.54) | 0.974 |
| WBC (103/μl) | 11190 (1990–40310) | 9200 (3620–24400) | 0.232 |
| AST (μL) | 33 (10–88) | 25 (10–56) | 0.367 |
| ALT (μL) | 25 (2–134) | 14 (4–185) | 0.643 |
| Platelet (103/μl) | 214000 (35000–925000) | 159000 (19810–430000) | 0.285 |
| 14 days | |||
| CRP (mg/mL) | 62 (22–295) | 105 (84–36) | 0.287 |
| PCT (mg/mL) | 1.21 (0.27–7.56) | 1.14 (0.98–1.30) | 0.909 |
| Laktat (mmol/L) | 1.44 (0.80–2.43) | 0.93 (0.63–2.38) | 0.181 |
| WBC (103/μl) | 9530 (1750–52230) | 8150 (3490–13500) | 0.274 |
| AST (μL) | 31 (7–124) | 36 (19–55) | 0.768 |
| ALT (μL) | 24 (4–169) | 14 (13–21) | 0.440 |
| Platelet (103/μl) | 190000 (40000–791000) | 214000 (21000–385000) | 0.813 |
ADMSCs: allogenic adipose-derived MSCs.